Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virus-Cell Interactions

Mouse-Human Heterokaryons Support Efficient Human Immunodeficiency Virus Type 1 Assembly

Roberto Mariani, Beth A. Rasala, Gabriel Rutter, Klaus Wiegers, Stephanie M. Brandt, Hans-Georg Kräusslich, Nathaniel R. Landau
Roberto Mariani
Infectious Disease Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beth A. Rasala
Infectious Disease Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel Rutter
Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg, D-20251 Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Wiegers
Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg, D-20251 Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie M. Brandt
Infectious Disease Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Georg Kräusslich
Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg, D-20251 Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathaniel R. Landau
Infectious Disease Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.75.7.3141-3151.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Processing ability of various rodent cell lines.M. musculus (MGT5.CyT, EL4.CyT, and L1-2.CyT), M. dunni (MDTF.CyT), hamster (CHO.CyT), or rat (Rat2.CD4.R5) cell lines with or without transfected hu-cyclin T1 were infected with NL4-3(VSV-G) at an MOI of 1. (A) Immunoblot analysis of infected cell lysates and virions pelleted from supernatant with anti-HIV serum. (B) Virion production of the infected cell lines. (C) Infectious titer of virus produced by the infected cell lines. Results are the average of triplicates. (D) Calculated ratio of TCID50 to supernatant p24gag from panels B and C.

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Electron microscopy of HIV-1 infected CHO and MDTF derivatives. (Upper panels) (a) Ultrathin sections were processed by glutaraldehyde-osmium fixation and ERL embedding. Budding structures (a) and extracellular HIV-1 particles are present. (b and c) Immunoelectron microscopy with anti-CA antibody of HIV-1-infected CHO derivative shows labeled budding structures (b) and adjacent extracellular particles (c). Gold particles are scarce in the cytoplasm and nearly absent in the extracellular space. (d and e) Gold-labeled HIV-like particles in the ER cisternae. Some cytoplasmic vacuoles (V) were labeled (arrow), while adjacent vacuoles remained unlabeled (arrowhead). (Lower panels) (a) Ultrathin sections of infected, fixed, and embedded MDTF.CD4.R5.CyT cells at low magnification showed virus particles at the plasma membrane. Morphological alterations were not observed. (b) Higher magnification revealed mature extracellular HIV-1 particles adjacent to the plasma membrane. (c) The extracellular particles were immunolabeled.

    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    CHO.CD4.R5.CyT but not other rodent cells support low-level HIV-1 replication. (A) MGT5.CyT, CHO.CD4.R5.CyT, MDTF.CD4.R5.CyT, LT4.R5.CyT, and HOS.CD4.R5 cells were infected with HXB.BaL and CHO.CD4.R5.CyT and HOS.CD4.R5 cells were also infected with NL-BaL at an MOI of 0.05, and p24gag production was measured over time. (B) CHO.CD4.R5.CyT and HOS.CD4.R5 were infected with HIV.YU2.GFP at an MOI of 0.05, and the percentage of green cells was scored by fluorescence-activated cell sorting analysis.

  • Fig. 4.
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    CHO cells are competent for coreceptor function but fail to support efficient virus replication. CHO.CD4.R5.CyT and HOS.CD4.R5 cells were infected with JR.FL pseudotyped firefly luciferase or VSV-G pseudotyped Renilla luciferase single-cycle reporter viruses. Luciferase activity was measured in cell lysates 3 days postinfection. The results are the averages of triplicates and are representative of three experiments.

  • Fig. 5.
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    The assembly defect in 3T3 cells is complemented by fusion to human cells. (A) Strategy for testing HIV assembly and production in mouse-human heterokaryons. MGT5.CyT, GHOST.R5, and MDTF.CD4.R5.CyT cells were infected at an MOI of 1 with NL4-3(VSV-G), washed three times, and fused 3 days later to 293T, 3T3, or MDTF cells. After 24 h postfusion, the cells were lysed for immunoblot analysis, and virions were collected for p24gag and TCID50 measurement. To control for input virus contamination, mock fusions in which PEG was omitted were analyzed in parallel. (B) p24gagconcentration in heterokaryon supernatants. (C) TCID50measurement of virus in heterokaryon supernatants. (D) TCID50 measurement of virus in M. dunni-human heterokaryon supernatants. (E) Immunoblot analysis of heterokaryon lysates using anti-HIV serum.

  • Fig. 6.
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Fusing human cells to infected murine cells that express hu-cyclin T1 increases LTR transactivation. Murine or human cells were infected with luciferase reporter virus. Three days postinfection, the cells were cocultivated with JR.FL Env-expressing or control cells for an additional 24 or 48 h to allow Env-mediated fusion between the two cell types. Luciferase activity in the cell lysates was then measured. Results are the averages of triplicates and are representative of three experiments.

PreviousNext
Back to top
Download PDF
Citation Tools
Mouse-Human Heterokaryons Support Efficient Human Immunodeficiency Virus Type 1 Assembly
Roberto Mariani, Beth A. Rasala, Gabriel Rutter, Klaus Wiegers, Stephanie M. Brandt, Hans-Georg Kräusslich, Nathaniel R. Landau
Journal of Virology Apr 2001, 75 (7) 3141-3151; DOI: 10.1128/JVI.75.7.3141-3151.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mouse-Human Heterokaryons Support Efficient Human Immunodeficiency Virus Type 1 Assembly
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mouse-Human Heterokaryons Support Efficient Human Immunodeficiency Virus Type 1 Assembly
Roberto Mariani, Beth A. Rasala, Gabriel Rutter, Klaus Wiegers, Stephanie M. Brandt, Hans-Georg Kräusslich, Nathaniel R. Landau
Journal of Virology Apr 2001, 75 (7) 3141-3151; DOI: 10.1128/JVI.75.7.3141-3151.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

cell fusion
HIV-1
virus assembly

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514